Impact Factor
2.91
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.25
114 total citations
h5-index
14
h5 depth signal
Cited share
71.7%
38 of 53
Total citations
114
Citation footprint
Metric signal
2.29
External metric anchor
Self-citation
1.8%
2 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
215
Canada
27
United Kingdom
22
Australia
12
Switzerland
9
Citing Fields of Research
Medical Ethics
185
Patient Care
42
Palliative Care
33
Genetics & Genomics
28
Scientometrics & Research Ethics
20
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
358
Articles tracked across the journal lifetime
Indexed publication set
53
38 cited publications
Last 12 months
23
2.6 publications/month
Open access share
26.1%
6 OA publications in the last year
Leading citing country
United States
215 citing publications
Leading citing field
Medical Ethics
185 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v8n1, 2017-
v8n1, 2017- ; Selected citations only before this date
Research Focus & Classification
Indexed Subjects
Medical Ethics
Broad Categories
Ethics
Medicine
Medical Ethics
Genetics & Genomics
Palliative Care
Psychiatry
Patient Care
MeSH Descriptors
Bioethical Issues
Ethics, Clinical
Ethics, Research
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/23294515.2026.2741040
Open DOI
What Does It Mean to Be Cured?: Perspectives from Individuals Living with Sickle Cell Disease
02
DOI 10.1080/23294515.2026.2741045
Open DOI
Clinician Mistrust in Patients: A Survey of Primary and Urgent Care Clinicians in Colorado
03
DOI 10.1080/23294515.2026.2718064
Open DOI
Does the Law Reflect Patient Preferences? Discordance Between Legal Surrogate Hierarchy and Chosen Surrogate Decision-Makers in Preoperative Patients
A surrogate decision maker (SDM) plays an important role in medical decision-making for a patient who is unable to make decisions (Mack et al. 2010; LoPresti et al. 2016; Yadav et al. 2017; Marks e...
04
DOI 10.1080/23294515.2026.2718056
Open DOI
In Algorithms We Trust? Stakeholder Perspectives on Algorithmic and AI-Based Survival Calculators
05
DOI 10.1080/23294515.2026.2718059
Open DOI
Organ Procurement Organization Perspectives on Normothermic Regional Perfusion Practices: A Qualitative Interview Study
Normothermic Regional Perfusion (NRP) is being used to expand the utilization of organs from donation after circulatory death (DCD) donors and improve transplant outcomes (Bekki et al. 2023; Wall e...
06
DOI 10.1080/23294515.2026.2718057
Open DOI
Facilitating Decision Making at End of Life: How Physicians’ Experiences Can Inform the Work of Clinical Ethicists
End-of-life treatment decisions can be morally complex. Decision makers often balance goals of prolonging life, optimizing quality of life, and supporting patient preferences around death amid prog...
07
DOI 10.1080/23294515.2026.2691711
Open DOI
Capturing Perceived Utility from Qualitative Studies of Genomic Sequencing: Translating a Conceptual Model into a Working Codebook
08
DOI 10.1080/23294515.2026.2691713
Open DOI
Who Receives Ethics Consultations? An Analysis of Racial and Ethnic Characteristics of an Ethics Consult Service in an Urban Academic Medical Center
As the population of the United States becomes more racially and ethnically diverse, navigating cultural differences between health care providers and their patients has become a standard part of e...
09
DOI 10.1080/23294515.2026.2691712
Open DOI
“I Have Someone’s Life in my Hands”: How Cancer Care Partners Experience and Navigate Moral Challenges
Cancer care partners (also known as caregivers or caretakers) are individuals without formal training or experience in cancer care who provide health or social support to others with cancer. Care partners are oftentimes family or friends...
10
DOI 10.1080/23294515.2026.2691708
Open DOI
“It’s an Uphill Battle. We Have a Long Way to Go”: Perspectives of Canadian Individuals Living with Genetic Conditions Detectable by Prenatal Cell-Free DNA Screening
In Canada, prenatal cell-free DNA screening is mainly used as a second-tier screening test that targets specific aneuploidies, namely trisomy 21, 18 and 13. Within the PEGASUS-2 study, we conducted in-depth interviews with 11 individuals...